CURRICULUM VITAE
Rose Marie Robertson (nee Stevens), M.D., F.A.C.C.
BORN: May 15, 1945 ‑ Detroit, Michigan
MARITAL STATUS: Married David Robertson, M.D.
FAMILY: Rose Marie - born February 2, 1983
COLLEGE: Manhattanville College ‑ Purchase, New York, B.A. 1966
MEDICAL SCHOOL: Harvard Medical School ‑ Boston, Massachusetts, M.D. 1970
.
POSTGRADUATE TRAINING
AND POSITIONS: Resident in Medicine, Massachusetts General Hospital, Boston, Massachusetts,
l970‑72
Teaching Fellow, Harvard Medical School, 1970‑72.
Medical Consultant, St Luke's Hospital, New Bedford, Massachusetts, 1972‑73
Postdoctoral Fellow in Cardiovascular Medicine, The Johns Hopkins Hospital, 1973‑75
Assistant Professor of Medicine, Vanderbilt University School of Medicine, 1975 - 1982
(on leave of absence 1977‑1978).
Assistant Professor of Medicine, The Johns Hopkins School of Medicine, 1977 ‑ 1978.
Associate Professor of Medicine, Vanderbilt University School of Medicine, 1982 - 1989.
Visiting Scientist, Royal College of Surgeons; Basic Science Institute, London, 1985
Associate Director, Division of Cardiology, Vanderbilt University Medical Center, 1987-96
Professor of Medicine, Vanderbilt University School of Medicine, 1989.
Investigator - Vanderbilt Center for Space Physiology and Medicine, 1990-present.
Vice-Chair for Academic Affairs, Department of Medicine, Vanderbilt University School of
Medicine, 1995-1999
Vice-Chairman Special Projects, Department of Medicine, 1999-present
Medical Director, Vanderbilt Women’s Heart Institute, 1999- present
Professor of Obstetrics and Gynecology, Vanderbilt University School of Medicine
Chief Science Officer, American Heart Association, 2002-present (on leave from Vanderbilt)
Honors and Awards: B.A. Cum Laude, Manhattanville College, 1966
M.D. Cum Laude, Harvard Medical School, 1970
Research Career Development Award, NHLBI, 1983 –Declined
Established Investigator, American Heart Association, July 1983‑June 1988
Gold Heart Award, American Heart Association, Tennessee, 1993
Award of Meritorious Achievement, American Heart Association, 1999
Partner in Public Health Award, Centers for Disease Control and Prevention, 2001
Licensure: State of Massachusetts, 1972
State of Maryland, 1973
State of Tennessee, 1975
Diplomate: Internal Medicine, 1974
Cardiovascular Medicine, 1975
Professional Societies: Nashville Academy of Medicine
American Society of Echocardiography
American Federation for Clinical Research
American Association for the Advancement of Science
Fellow, American Heart Association
Fellow: American College of Cardiology
Fellow, Southern Society for Clinical Investigation
American Institute of Aeronautics and Astronautics
American Society for Clinical Investigation
Association of University Cardiologists
American Clinical and Climatological Association
American Autonomic Society - Founding Member
Association for Patient-Oriented Research – Founding Member
Fellow, European Society of Cardiology
American Heart Association -- Tennessee:
Chairman, Professional Education Committee, Middle Tennessee Chapter ‑ 1978‑80
Chairman, Professional Education Committee, Tennessee Affiliate ‑ 1980‑1982
Research Peer Review Committee, Tennessee Affiliate 1984-1987
Board of Directors, Middle Tennessee Chapter, 1982‑1987
Chairman, Medical and Community Programs - Middle Tennessee Chapter 1986-1987
President, Davidson County Unit, 1987-88
President, Tennessee Affiliate 1989-1990
Chairman, Tennessee Affiliate-Committee on Diversity (1990-1992)
Board of Directors, Tennessee Affiliate, 1988-1998
Board of Directors, Southeast Affiliate, 1998-present
American Heart Association -- National:
Council on Circulation
Council on Basic Science
Council on Basic Cardiovascular Sciences
Fellow, Council on High Blood Pressure Research
National Task Force on Cholesterol Issues -1989-1992
National Task Force on Metropolitan Organization-1992-1994
National Women and Minority Leadership Committee, 1992-1995
Scientific Advisory and Coordinating Committee 1993-present
Task Force on Fetal Tissue Research 1994-1995
Board of Directors, 1994-present
Scientific Sessions Program Committee 1993-1998; Vice-Chair 94-96; Chair 96-98
Programs and Projects Budget Subcommittee 1995-1999, Chair 1998-1999
Strategic Integration Taskforce, 1995-1996
Stroke Positioning Taskforce, Co-Chair 1996-1997
Science and Medicine Information Committee 1996-1997
Task Force on Councils in the 21st Century 1998-1999, Chair
Acute Event Strategic Group 1999-2000, Chair
President-Elect, American Heart Association 1999-2000
President, American Heart Association, 2000-2001
Chief Science Officer, 2003 to present
Robert Wood Johnson Foundation
Minority Medical Faculty Program-National Advisory Committee 1990-present, Chair 2003-present
American College of Cardiology
Young Investigator Committee 1990-1994
Annual Meeting Program Committee 1996-1998
European Society of Cardiology
Scientific Sessions Program Committee 1996-1998
INVITED SPEAKER:
1. Symposium on Coronary Artery Spasm. Seville, Spain. Sponsored by Association of Spanish Cardiologists, September 23‑25, 1981.
2. Symposium on Coronary Artery Spasm ‑ New York Academy of Science. New York, New York, 1981.
3. 14th Annual Cardiovascular Symposium. New York, New York. Sponsored by American College of Cardiology and New York Medical College, December 11‑13, 1981.
4. Calcium Blockers in the Management of Cardiovascular Disease. Montreal, Quebec. Sponsored by the Institute de Cardiologie de Montreal, February 11‑12, 1982.
5. Platelets and Coronary Artery Spasm. Symposium on Platelets and Ischemic Heart Disease held in conjunction with the Annual Scientific Sessions ‑ American College of Cardiology, 1982.
6. Antiplatelet Drugs in Ischemic Heart Disease ‑ Luncheon Panel at Annual Scientific Sessions ‑ American College of Cardiology, 1982.
7. Mechanisms of Coronary Vasospasm. Postgraduate Seminar ‑ Councils on Basic Science and Circulation. Held in conjunction with the 56th Annual Scientific Sessions ‑American Heart Association, 1983.
8. Prostaglandins in Cardiovascular Diseases. Cardiovascular Conferences. Held in conjunction with the 56th Annual Scientific Sessions ‑ American Heart Association, 1983.
9. How to Treat Patients with Unstable Angina. How To Sessions. Held in conjunction with the 56th Annual Scientific Sessions ‑ American Heart Association, 1983.
10. Pathophysiologic Mechanisms of Coronary Artery Spasm ‑ Hammersmith Hospital, London, 1985.
11. New Concepts in Myocardial Ischemia ‑ Royal Infirmary, Edinburgh, 1985.
12. Autonomic Influences on Coronary Artery Tone ‑ University Department of Cardiology, Freeman Hospital, Newcastle‑Upon‑Tyne, England, 1985.
13. Participant, NIH Workshop on Myocarditis, September, 1985.
14. Abnormalities of Coronary Blood Flow ‑ University of Oklahoma Medical Center, 1986.
15. Participant, NIH Symposium on Molecular and Cellular Mechanisms of Myocardial Ischemia, September, 1986.
16. Participant, Mini-Course on Unstable Angina Pectoris - American College of Cardiology Scientific Sessions, March 1987.
17. Co-Director, European and American Cardiology. Basic Mechanisms in Cardiovascular Diseases: Implications for Prevention and Therapy, Royal Postgraduate Medical School (London), June 1987.
18. Visiting Professor: National Defense Medical Center and National Taiwan University, Taipei, People's Republic of China, August, 1987.
19. Fireside Panel, American College of Cardiology Annual Scientific Sessions. Antiplatelet Therapy: Principles and Practice, March 1988.
20. Invited Speaker: FASEB Theme Symposium: Coronary Vasospasm, Las Vegas, May 1988.
21. Invited Speaker: FASEB Summer Research Symposium: The Endothelium, Copper Mountain, Colorado, August 7-12, 1988.
22. Invited Speaker: ILSI-6th International Caffeine Workshop, Hong Kong, August, 1989.
23. Invited Speaker: Association of University Cardiologists Annual Meeting: Carmel, California, January 1991.
24. Chairman: ACC Core Curriculum: Advances in Cardiovascular Pharmacology. Atlanta, Georgia, March 1991.
25. 90th Anniversity Celebration - National Defense Medical Center - Taipei. Symposium on Cardiovascular Diseases - Basic and Clinical Aspects. November,1992.
26. National Cheung-Kung Medical School - Tainan, December, 1992.
27. Invited Speaker: 9th Annual CardioStim Meeting - Symposium on Sudden Cardiac Death. Nice, April, 1994.
28. Chair: European Society of Cardiology Annual Meeting-Symposium on Cardiovascular Control, Stockholm - August 1997
29. Invited Speaker, Cleveland Clinic: Neurocardiogenic Syncope – October, 1999.
30. Co Chair: European Society of Cardiology Annual Meeting – Symposium on Syncope, Amsterdam – August 2000
31. Co-Chair: Plenary Session AHA Annual Scientific Sessions – New Orleans, November, 2000
32. Invited Speaker, Curso Interamericano de Hipertension – Acapulco, June 2001
33. Invited Speaker, University of Michigan -- Cardiology Grand Rounds– July, 2001
34. Invited Speaker, Cardiology Grand Rounds – Baylor College of Medicine – Houston, January 2002
35. Invited Speaker, Cardiology Grand Rounds – UT Houston, January, 2002
36. Invited Speaker: Symposium on CAD in Women, World Congress of Cardiology – Sydney, May,2002
RESEARCH REVIEWER:
Research Peer Review Committee ‑ AHA Tennessee Affiliate ‑ 1984‑1987
Ad Hoc Reviewer ‑ NHLBI SCORs in Ischemic Heart Disease ‑ 1984
NHLBI Special Review Committee on Supplemental Applications to SCORs in
Ischemic Heart Disease ‑ 1986
NHLBI Program Project Committee, Ad Hoc Reviewer-1992
NASA -Life Sciences Disciplinary Implementation Group- Johnson Space Center, Houston-1993
NHLBI Study Section-Cardiovascular B-1992-96
VA Merit Review - Ad Hoc Reviewer
Editorial Boards - American Journal of the Medical Sciences; Circulation
Journal Reviewer ‑ Circulation, Journal of the American College of Cardiology, American Journal of Cardiology,
American Heart Journal, Annals of Internal Medicine, Chest, Circulation Research, Journal of Clinical
Investigation, Hypertension, Peptides
TEACHING:
Lectures in College of Arts and Sciences
Physiology – 1997-2002
Lectures in Medical School Curriculum
Cardiology Elective (1st year) ‑ 1975‑1985
Psychiatry – (1st year)1995-present
Pharmacology (1st year) - 1992-2002
Cardiac Physical Diagnosis (2nd yr.) ‑ 1975‑1988
Medicine (3rd yr.) ‑ 1980‑1985
Clinical Management Course (4th yr) 1984-present
House Officer/Student Teaching
Attending Physician (2 mos/yr) VA ‑ 1975‑77, 1999-2002t
Attending Physician Autonomic Service (1‑3 mos/yr) VUH ‑ 1975‑2002
Cardiology Teaching Rounds (1‑3 mos/yr) VUH ‑ 1975‑1997
Electrocardiography (1-2 months/yr) 1993-1999
CCU (Harrison Service) 1999 – 2002
Medical Students
(summer and Introduction to Biomedical Research):
Jessilee Northington 1983‑86 (2 months each summer)
Patrice Washington 1986 (2 months)
Brian Daniels 1987-89 (2 months each summer)
John Warner 1989-91(2 months each summer)
Darryl S. Wells 1998
Sonal Saraswat 1999
Joy Duong 1999
Elizabeth Atkinson 1999
Yasmine Ali 2000
American Heart Association Sponsored Research for Medical Students
Connor Haugh 1987-1988 (12 months)
POSTDOCTORAL RESEARCH FELLOWS:
W. Eugene Harston, M.D. 1976‑1977
Robert Boswell, M.D. 1978‑1979
James E. Barnhill, M.D. 1981‑1982
William W. Ellis, M.D. 1980‑1982
Mervyn B. Forman, M.D. 1981‑1983
Louis Roy, M.D. 1982‑1983
Thomas B. Gore, M.D. 1983‑85
Maria Victoria Tantengco, M.D. 1984‑86
Bjarki Olafsson, M.D. 1985‑1987
Charles R. Prince, M.D. 1985‑1987
Takashi Susawa, M.D. 1987-1989
Thomas J. Killian, M.D. 1989-1991
Mark Angel, M.D. 1991-1993
Todd Gary, Ph.D. 1992-1994
Giris Jacob, M.D. 1995-1996
Andrew Ertl, Ph.D. 1993- 1996
Jens Jordan, M.D. 1996-1998
Igbal Singh M.D. 1996-1998
Nihal Shah, M.D. 1998-1999
Susan Naselli, M.D. 2000-2001
Sarita Kansal, M.D. 2001-2002
Simi Vincent, MD, PhD. 2001-2003
COMMITTEE WORK - VANDERBILT
Past:
Medical Records Committee
CPR Committee
Committee for the Protection of Human Subjects (Chair 1988-89)
CCU Committee
Transplant Executive Committee
Department of Medicine Appointments and Promotions Advisory Committee (1990-93)
Medical Center Board (1990-1994)
University Faculty Senate (1991-94)
School of Medicine Appointments and Promotion Committee (1990-1994; Chair 1992-1994)
Admissions Committee of the School of Medicine (1992-1995)
Search Committee: Director of Nephrology
Search Committee: Director of General Internal Medicine
Search Committee: Director of Clinical Epidemiology
Search Committee: Director of Diabetes/Endocrinology
Department of Medicine Awards Committee
School of Medicine Appointments and Promotion Committee
Curriculum Review Committee: Cardiovascular, Hematologic, and Kidney Diseases
Chair: Curriculum Review Committee-Cardiovascular Diseases
Department of Medicine Committee on the Clinical Investigator Track
Department of Medicine Committee on Salary Structure
RESEARCH SUPPORT
Yearly Award Levels Prior to Beginning Leave of Absence:
1. NHLBI: PPG Autonomic Cardiovascular Regulation. PI Project 2; Director Core B (7/1997- 6/2002); $626,468.
2. NHLBI: RO-1 Pharmacologic Probes in Neurally-Mediated Syncope. PI. (8/1/2000-7/30/2004); $150,000
3. Carbomed: Autonomic Effects of CM 101 in Patients with Spinal Cord Injury (8/2001-7/2002); $178,000
PUBLICATIONS
A.
Original Investigations (née Stevens)
1. Stevens RM, Teres D, Feingold D: Pneumonia in an intensive care unit. Arch Int Med 1974; 134: 106.
2. Robertson D, Stevens RM, Friesinger GC, Oates JA: The effect of the Valsalva maneuver on echocardiographic dimensions in man. Circulation 1977; 55: 596‑602.
3. Brawley RK, Schaff H, Stevens RM, Ducci H, Gott VL, Donahoo JS: Influence of coronary artery anatomy on survival following resection of left ventricular aneurysms and chronic infarcts. J Thor Cardiovasc Surg 1977; 73: 120‑128.
4. Harston WE, Robertson RM, and Friesinger GC: Echocardiographic evaluation of porcine heterograft values in the mitral and aortic positions. Am Heart J 1978; 96: 448‑457.
5. Steckley R, Smith CW, Robertson RM: Acute right ventricular overload: An echocardiographic clue to pulmonary thromboembolism. Johns Hopkins Med J 1978; 143: 122‑125.
6. Robertson D, Robertson RM, Nies AS, Oates JA, Friesinger GC: Variant angina pectoris: Investigation of indices of sympathetic nervous system function. Am J Cardiol 1979; 43: 1080‑1085.
7. Robertson D, Johnson GA, Robertson RM, Nies AS, Shand DG, Oates JA: Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation 1979; 59: 637‑643.
8. Robertson RM, Breinig JB, Robertson D: Chronic recurrent variant angina. Southern Med J 1979; 72: 1297‑1303.
9. Rigo P, Alderson PO, Robertson RM, Becker LC, Wagner HN: Measurement of aortic and mitral regurgitation by gated cardiac blood pool scans. Circulation 1979; 60: 206‑312.
10. Wood AJJ, Robertson D, Robertson RM, Wilkinson GR, Wood M: Elevation of plasma free drug concentrations of propranolol and diazepam during cardiac catheterization. Circulation 1980; 62: 1119‑1122.
11. Robertson RM, Robertson D, Friesinger GC, Timmons S, Hawiger J: Platelet aggregates in peripheral and coronary sinus blood in patients with spontaneous coronary artery spasm. Lancet; 1980; 2: 829‑831.
12. Robertson D, Robertson RM: The Bezold‑Jarisch reflex: Possible role in limiting myocardial ischemia. Clin Cardiol 1981; 4: 75‑79.
13. Robertson RM, Robertson D, Roberts LJ, Maas RL, Fitzgerald GA, Friesinger GC, Oates JA: Thromboxane A2 in vasotonic angina pectoris: Evidence from direct measurements and inhibitor trials. N Eng J Med 1981; 304: 998‑1003.
14. Robertson D, Wade D, Robertson RM: Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunctional states. Am J Cardiol 1981; 48: 1048‑1052.
15. Robertson RM, Wood AJJ, Vaughn WK, Robertson D: Exacerbation of vasotonic angina pectoris by propranolol. Circulation 1982; 65: 281‑285.
16. Kronenberg MW, Robertson RM, Born ML, Steckley RA, Robertson D, Friesinger GC: Thallium‑201 uptake in variant angina: Probable demonstration of myocardial reactive hyperemia in man. Circulation 1982; 66: 1332‑1338.
17. Kronenberg MW, Price RR, Smith CW, Robertson RM, Perry JM, Pickens DR, Domanski MJ, Partain CL, Friesinger GC: Evaluation of left ventricular performance using digital subtraction angiography. Am J Cardiol 1982; 51: 837‑842.
18. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM: Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am J Med. 1983; 74: 193‑199.
19. Robertson RM, Bernard Y, Robertson D: Arterial and coronary sinus catecholamines in the course of spontaneous coronary artery spasm. Am Heart J; 1983; 105: 901‑906.
20. Robertson RM, Bernard YD, Carr RK, Robertson D: Alpha‑adrenergic blockade in vasotonic angina: Lack of efficacy of specific alpha‑1 blockade with prazosin. J Amer Coll Cardiol 1983; 2: 1146‑1150.
21. Forman MB, Byrd B, Oates JA, Robertson RM: Two dimensional echocardiography in the diagnosis of carcinoid heart disease. Am Heart J 1984; 107: 492‑496.
22. Forman MB, Robertson D, Goldberg M, Bostick D, Uderman H, Perry JM, Robertson RM: The effect of tyramine on myocardial catecholamine release and coronary blood flow in man. Amer J Cardiol 1984; 53: 476‑480.
23. Forman MB, Virmani R, Robertson RM, Stone, WJ: Mitral anular calcification in chronic renal failure. Chest 1984; 85: 367‑371.
24. Robertson D, Hollister AS, Carey EL, Tung C, Goldberg MR, Robertson RM: Increased vascular beta2‑adrenoreceptor responsiveness in autonomic dysfunction. JACC 1984;3:850‑856.
25. Fitzgerald DJ, Roy L, Robertson RM, FitzGerald GA: The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. Circulation 1984;70:297‑302.
26. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM: Baroreceptor dysfunction in man. Am J Med 1984; 76:A49-A58.
27. Forman MB, Byrd, BF, Kopelman H, Robertson RM, Virmani R: Value of two‑dimensional echocardiography in the diagnosis of carcinoid heart disease. Cardiology Board Review 1984;1:89‑103.
28. Roy L, Knapp HR, Robertson RM, FitzGerald GA: Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. Circulation 1985;71:434‑440.
29. Barnhill JE, Wikswo JP Jr, Dawson AK, Gundersen S, Robertson RM, Robertson D, Virmani R, Smith RF: The QRS complex during transient transmural myocardial ischemia: studies in patients with variant angina pectoris and in a canine preparation. Circulation 1985;71:901‑911.
30. Forman MB, Phelan BK, Robertson RM, Virmani R: Correlation of two‑dimensional echocardiography and pathologic findings in porcine valve dysfunction. J Am Coll Cardiol 1985;5:224‑230.
31. Forman MB, Uderman H, Jackson EK, Roy L, Bostick D, Robertson D, Robertson RM: Effects of indomethacin on systemic and coronary hemodynamics in patients with coronary artery disease. Am Heart J 1985;110:311‑318.
32. Robertson D, Hollister AS, Forman MB, Robertson RM: Reflexes unique to myocardial ischemia and infarction. J Am Coll Cardiol 1985; 5:99B‑104B.
33. Forman MB, Oates JA, Roberts JH, Robertson RM, Virmani R: Increased adventitial mast cells in a patient with proven coronary spasm. New Engl J Med 1985;313:1138‑41.
34. Ellis WW, Baer AN, Robertson RM, Pincus T, Kronenberg MW: Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis. Am J Med 1986; 80:385‑392.
35. Robertson D, Goldberg MR, Onrot J, Hollister AS, Wiley R, Thompson JG, Robertson RM: Isolated failure of autonomic noradrenergic neurotransmission: Evidence for impaired beta-hydroxylation of dopamine. New Engl J Med 1986; 314:1494-1497.
36. Robertson D, Goldberg MR, Tung C-H, Hollister AS, Robertson RM: Use of alpha2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. J Clin Invest 1986; 78:576-581.
37. Cates CU, Virmani R, Vaughn WK, Robertson RM: Electrocardiographic markers of cardiac metastases. Am Heart J 1986; 112:1297-1303.
38. Hondeghem L, Ayad M, Robertson RM: Verapamil, diltiazem and nifedipine block the depolarization‑induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries. J Pharm Exp Ther 1986; 239:808-813.
39. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D: Cardiovascular effects of adenosine infusion in man and their modulation by dipyridamole. Life Sci 1986; 39:2229-2236.
40. Biaggoni I, Olafsson B, Robertson RM, Hollister AS, Robertson D: Cardiovascular and respiratory effects of adenosine in conscious man: Evidence for chemoreceptor activation. Circ Res 1987; 61:779-786.
41. Roberts LJ, II, Seibert K, Liston TE, Tantengco MV, Robertson RM: PGD2 is transformed by human coronary arteries to 9a, 11b PGF2, which contracts human coronary artery rings. Adv Prostaglandin Thromboxane Leukotriene Res 1987; 17A:427-9.
42. Tseng C-J, Robertson D, Light RT, Atkinson JB, Robertson RM: Neuropeptide Y is a vasoconstrictor of human coronary arteries. Am J Med Sci 1988; 296(1):11-16.
43. Rea RF, Biaggioni I, Robertson RM, Haile V, Robertson D. Reflex control of muscle sympathetic nerve activity in dopamine-beta-hydroxylase deficiency. Hypertension 1990; 15:107-112.
44. Mosqueda-Garcia R., Tseng G, Biaggioni I, Robertson RM, Robertson D. Effects of caffeine on baroreflex activity in man. Clin Phar Ther 1990; 48:568-574.
45. Biaggioni I, Killian TJ, Mosqueda-Garcia R, Robertson RM, Robertson D: Adenosine increases sympathetic nerve traffic in humans. Circulation 1991; 83:1668-1675.
46. Robertson D, Haile V, Perry SE, Robertson RM, Phillips JA, Biaggioni I: Dopamine beta-hydroxylase deficiency: A genetic disorder of cardiovascular regulation. Hypertension 1991; 18:1-8.
47. Moliterno D, DeBold CR, Robertson RM: Coronary vasospasm: Relationship to the hyperthyroid state. Am J Med Sci 1992; 304:38-42.
48. Robertson D, Biaggioni I, Mosqueda-Garcia R, Robertson RM: Orthostatic hypotension of prolonged weightlessness: Clinical Models. Acta Astronautica 1992; 27:97-101.
49. Robertson D, Mosqueda-Garcia R, Robertson RM, Biaggioni I: Chronic hypotension: In the shadow of hypertension. Am J Hypertension 1992; 5:200S-205S.
50. Mosqueda-Garcia R, Inagami T, Appalsamy M, Sugiura M, Robertson RM. Endothelin as a neuropeptide: Cardiovascular effects in the brainstem of normotensive rats. Circ Res 1993; 72:20-35.
51. Robertson D, Hollister AS, Biaggioni I, Mosqueda-Garcia R, Netterville JL,Robertson RM: The diagnosis and treatment of baroreceptor failure in man. New Engl J Med 1993: 329: 1449-1455.
52. Biaggioni I, Robertson RM, Robertson D: Manipulation of norepinephrine metabolism with yohimbine in the trreatment of autonomic failure. J Clin Pharmacol 1994; 34:418- 423.
53. Robertson D, Robertson RM: Etiology of chronic orthostatic hypotension: A prospective study. Arch Int Med 1994; 154:1620-24 .
54. Robertson D, Kincaid DW, Robertson RM: The head and neck discomfort of autonomic failure: An unrecognized etiology of headache. Clin Autonom Res 1994; 4:99-103.
55. Pokudin NI, Menshikov MYu, Robertson D, Robertson RM, Hollister AS, Orlov SN, Tkachuk VA, Postnov YuV: Raised free calcium in the platelet of the spontaneously hypertensive rat: regulation by ADP and epinephrine. Curr Ther Res 1994; 55:290-302.
56. Mitsky VP, Workman RJ, Nicholson E, Vernikos J, Robertson RM, Robertson D: A sensitive radioimmunoassay for fludrocortisone in human plasma. Steroids 1994;59:555- 558.
57. Carey EL Jr, Robertson D. Wells JN, Robertson RM. Contraction of isolated porcine coronary arteries is inhibited by high concentrations of propranolol. Angiology 1995; 46:453-460.
58. Jacob G, Shannon J, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D: Effects of Volume Loading and Pressor Agents in Idiopathic Orthostatic Tachycardia. Circ 1997; 96: 575-80
59. Jacob G, Robertson D, Mosqueda-Garcia R, Ertl A, Robertson RM, Biaggioni I: Hypovolemia in Syncope and Orthostatic Intolerance. Role of Renin-angiotensin System. Am J Med 1997; 103:128-33
60. Ernst FA, Jackson I, Robertson RM, Nevels H, Watts E: Skin tone, hostility, and blood pressure in young normotensive African Americans. Ethnicity & Disease 1997; 7:34-40.
61. Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, Desai T, Snell M, Jarai Z, Ananthram V, Robertson RM, Robertson D: Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest 1997: 99:2736-44.
62. Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I: The hypertension of autonomic failure and its treatment. Hypertension 1997; 30:1062-7
63. McDermott DS, Ernst FA, Nevels H, Robertson RM. Blood pressure response to orthostatic and mental challenge in African-American women taking oral contraceptives. J Fam Pract 1997; 45: 237-242
64. Jacob G, Ertl AC, Shannon JR, Furlan R, Robertson RM, and Robertson D: Effect of Standing on Neurohumoral Responses and Plasma Volume in Healthy Subjects J Appl Physiol 1998; 84: 914-21
65. Jacob G, Biaggioni I, Mosqueda-Garcia I, Robertson RM, Robertson D: The Relation of Blood Volume and Blood Pressure in Orthostatic Intolerance Am J Med Sci 1998; 31:95-100.
66. Choy AMJ, Lang C, Roden D, Robertson D, Wood A, Robertson RM, Biaggioni I: Abormalities of the QT Interval in Primary Disorders of Autonomic Failure. Am Heart J 1998; 136:664-671
67. Jordan J, Shannon J, Pohar B, Robertson D, Robertson RM, Biaggioni I: Contrasting Effects of Vasodilators on Blood Pressure and Sodium Balance in Hypertension of Autonomic Failure. J Am Soc Neph 1999; 10:35-42.
68.
Jacob G, Shannon JR, Costa F, Furlan R, Biaggioni I,
Mosqueda-Garcia R, Robertson RM, Robertson D.
Idiopathic orthostatic intolerance:
Abnormalities in norepinephrine kinetics and sensitivity to adrenergic
agonists. Circulation 1999;
(13):1706-12
69. Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl AC, Black B, Robertson D. The neuropathic postural tachycardia syndrome. New Eng J Med 2000; 343: 1008-1014.
70. Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F, Diedrich A, Robertson RM, Biaggioni I, Robertson D. The pressor response to water drinking in humans - A sympathetic reflex? Circulation 2000; 101: (5) 504-509.
71. Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl AC, Black B, Robertson D. The neuropathic postural tachycardia syndrome. New Eng J Med 2000; 343: 1008-1014.
72. Kriketos AD, Robertson RM, Sharp TA, Drougas H, Reed
GW, Storlien LH, Hill JO. Role of weight loss and polyunsaturated fatty acids
in improving metabolic fitness in moderately obese, moderately hypertensive
subjects.
Journal of Hypertension. 2001;19:1745-1754.
73. Ertl, AC, Diedrich A, Biaggioni I, Levine B, Robertson RM, Cox J, Zuckerman JH, Pawelczyk JP, Ray CA, Buckeyt JC, Lane LD, Shiavi R, Gaffney FAG, Costa F, Holt C, Blomqvist G, Eckberg D, Baisch F, Robertson D. Human muscle sympathetic nerve activity and plasma noradrenaline kinetics in space. Journal of Physiology 2002, 538.1. 321-329
74. Shannon JR, Diedrich A, Biaggioni I, Tank J, Robertson RM, Robertson D, Jordan J. Water drinking as a treatment for orthostatic syndromes. Am J Med. 2002 Apr 1;112(5):419-21.
75. Cox JF, Tahvanainen KUO, Kuusela TA, Levine BD, Cooke WH, Mano T, Iwase S, Saito M, Sugiyama Y, Ertl AC, Biaggioni I, Diedrich A, Robertson RM, Zuckerman JH, Lane LD, Ray CA, White RJ, Pawelczyk JA, Buckey JC Jr, Baisch FJ, Blomqvist CG, Robertson D and Eckberg DL. Influence of microgravity on astronauts' sympathetic and vagal responses to Valsalva's manoeuvre. Journal of Physiology 2002, 538.1. 309-320.
76. Levine BD, Pawelczyk JA, Ertl AC, Cox JF, Zuckerman JH, Diedrich A, Biaggioni I, Ray CA, Smith ML, Iwase S, Saito M, Sugiyama Y, Mano T, Zhang R, Iwasaki K, Lane LD, Buckey JC, Cooke WH, Baisch FJ, Robertson RM, Robertson D, Eckberg DL, Blomqvist CG. Human muscle sympathetic neural and haemodyanmic responses to tilt following spaceflight. J. Physiol, 2002; 538.1:331-340
77. Fu Q, Levine BD, Pawelczyk, Ertl AC. Diedrich A, Cox JF, Zuckerman JH, Ray CA, Smith ML, Iwase M, Sugiyama Y, Mano T, Zhang R, Iwasaki K, Lane LD, Buckey JC, Cooke WH, Robertson RM, Baisch FJ, Blomqvist G, Eckberg DL, Robertson D, Biaggioni I. Cardiovascular and sympathetic neural responses to handgrip and cold pressor stimuli in humans before, during and after spaceflight. J Physiology 2002; 544: 653.
78. Ketch T, Biaggioni I, Robertson R, Robertson D. Four Faces of Baroreflex Failure: Hypertensive Crisis, Volatile Hypertension, Orthostatic Tachycardio, and Malignant Vagotonia. Circulation 2002; 105(21): 2518-23
79. Tank J, Diedrich A, Hale N, Niaz FE, Furlan R, Robertson RM, Mosqueda-Garcia R. Relationship between blood pressure, sleep K-complexes, and muscle sympathetic nerve activity in humans. Am J Physiol Regul Integr Comp Physiol 2003; 285: R208-R214.
80. Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking Women’s Awareness of Heart Disease: An American Heart Association National Study. Circulation. 2004;109:573-579.
81. Ferris
A, Robertson RM, Fabunmi R,
Mosca L. American Heart Association and
American Stroke Association National Survey of Stroke Risk Awareness. Circulation.2005; 111: 1321-1326.
B. Non‑Experimental Articles
1. Stevens RM, Fortuin NJ: Echocardiography, Maryland State Med J 1975; 24: 5.
2. Robertson D, Stevens RM: Nitrates and glaucoma. (Letter) JAMA 1977; 237: 117.
3. Robertson RM: Variant angina: The Johns Hopkins Postgraduate Course in Internal Medicine. Vol. 4, Program VII (1978).
4. Robertson RM, Robertson D: Vasotonic angina ‑ a review. JAMWA 1980; 35:229‑235.
5. Goldberg MR, Robertson RM, Robertson D: Atrial tachypacing for primary orthostatic hypotension. (Letter) N Eng J Med 1980; 303: 885‑886.
6. Robertson D, Robertson RM: Variant angina pectoris and sympathetic nervous system function.
(Letter) Am J Cardiol 1980; 48:701.
7. Smith B, Robertson RM, Robertson D: An early southern description of Curschmann's spirals. Clin N Resp Dis 1982; 21: 10‑12.
8. Robertson D, Robertson RM, Smith WB: The dominance of scientific English: One language or two? J Amer Med Assn 1983; 250: 3196‑3198.
9. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM: Baroreceptor dysfunction in man. Amer J Med 1984; 76:A49‑A58.
10. Robertson D, Robertson RM: Orthostatic hypotension: Diagnosis and therapy. Mod Con Cardiov Dis 1985;54:7‑12.
11. Hillis D, Frishman W, Leon M, Packer M, Robertson RM, Subramanian B, Winniford M: Current perspective in angina: therapeutic approaches. Cardiovascular Reviews & Reports 1985;6:709‑718.
12. Robertson D, Robertson RM: Orthostatic hypotension. Acute Care 1985;2:24-27.
13. Friesinger GC, Robertson RM: Vasospastic Angina: A continuing search for mechanisms. JACC 1986;7:30-31.
14. Friesinger GC, Robertson RM: Possible mechanisms of coronary artery occlusion. European Heart Journal 1986;6:11‑19.
15. Tantengco MV, Onrot J, Robertson D, Robertson RM, Light RT: Orthostatic hypotension: clinical spectrum and approach to treatment. Comprehensive Therapy, 1986; 12:41-47.
16. Onrot J, Goldberg MR, Hollister AS, Biaggioni I, Robertson RM, Robertson D: Management of chronic orthostatic hypotension. Am J Med 1986;80:454‑464.
17. Friesinger GC, Robertson RM: Silent myocardial ischemia. Current Opinion in Cardiology 1987; 2:961-971.
18. Biaggioni I, Jackson EK, Robertson RM, Robertson D. Caffeine and hypertension. In: Nutrition and
19. Hypertension in Blacks and Other Minorities. Ed: Enwonwu C.O. Annual Nutrition Workshop Series (Nashville: Vaughn, Inc.) 1989;2:199-206
20. LaRosa JC, Hunninghake D, Bush D, Criqui MN, Getz GS, Gotto AM Jr., Grundy SM, Rakita L, Robertson RM, Weisfeldt ML. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation 1990; 81:(5) 1721-33
21. Robertson RM, Biaggioni I, Mosqueda-Garcia R, Robertson D: Autonomic dysfunction: Diagnosis guided by therapy. Trans Am Clin Clim Assoc 1991; 103:228-237.
22. Robertson D, Jacob G, Ertl A, Shannon J, Mosqueda-Garcia R, Robertson RM, Biaggioni I: Clinical models of Cardiovascular Regulation After Weightlessness. Med & Sci in Sports & Exer 1996;28:S80-4 (Suppl)
23. Strauss WE, Thies WH, Robertson RM, Adams H. Fighting heart disease and stroke - Recommendations of the AHA stroke positioning task force. Stroke 1998; 29: (6) 1272-1273.
24. Bonow RO, Mensah GA, Bettmann MA, Gibbons GH, Grant AO, Jalife J, Robertson RM. The working group report on science-based categories for abstracts submitted to the Annual Scientific Sessions. Circulation 1998; 97: 1525-1528; Circ Res 1998; 82: 832-835; Hypertension 1998; 31: 1042-1045; Stroke 1998; 29: 881-884.
25. Robertson RM, Medina E, Shah N, Furlan R, Mosqueda-Garcia R: Neurally-mediated syncope: Pathophysiology and implications for treatment. Am J Med Sci 1999; 317: 102-109
26. Robertson D, Biaggioni I, Ertl AC, Robertson RM, Diedrich A, Blakely RD, Flattem N, Shannon JR. Orthostatic intolerance: emerging genetic and environmental etiologies. J Gravit Physiol. 1999 ; 6(1) : P51-4
27. Robertson RM. Sudden death from cardiac arrest - Improving the odds. Invited editorial. New Engl J Med 2000; 343: 1259-1260
28. Robertson RM, Smaha L. Can a Mediterranean-style diet reduce heart disease?. Invited editorial. Circulation 2001; 103: 182.
29. Robertson RM. Women and Cardiovascular Disease: The Risks of Misperception and the Need for Action. Editorial. Circulation 2001; 103: 2318.
30. Robertson RM. Partnerships for the Health of the Public. Editorial. Circulation 2001; 103: 2870.
31. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith SC, Taubert KA, Wenger NK. Hormone Replacement Therapy and Cardiovascular Disease. A statement for healthcare professionals from the American Heart Association. Circulation 2001; 103:499.
32. Adams R, Acker J, Alberts M, Andrews L, Atkinson R, Fenelon K, Furlan A, Girgus M, Horton K, Hughes R, Koroshetz W, Latchaw R, Magnis E, Mayberg M, Pancioli A, Robertson RM, Shephard T, Smith R, Smith SC Jr, Smith S, Stranne SK, Kenton EJ 3rd, Bashe G, Chavez A, Goldstein L, Hodosh R, Keitel C, Kelly-Hayes M, Leonard A, Morgenstern L, Wood JO. Recommendations for improving the quality of care through stroke centers and systems: an examination of stroke center identification options: multidisciplinary consensus recommendations from the Advisory Working group on Stroke Center Identification Options of the American Stroke Association. Stroke 2002; 33(1): e1-7
33. Hormone replacement therapy and cardiovascular disease – Response. Mosca L, Collins P, Herrington DM, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith SC, Taubert KA, Wenger NK. Circulation 2002; 105: e71-72.
34. Biaggioni I, Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin. 2002 May;20:291-301.
35. Mosca L, Appel
LJ,. Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady Haan CK,
Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC,
Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC, Jr, Sopko G, Taylor AL,
Walsh BW, Wenger N, Williams CL, MD
American
Heart Association Scientific Statement. Evidence-based guidelines for
cardiovascular disease prevention in women.
Circulation 2004; 109:672-693.
36. Bonow RO, Zipes DP, Anderson JL, Cheitlin MD, Goldstein LB, Grant AO, Faxon D, Lima JAC, Robertson RM. Task Force 5: Expert Testimony and Opinions. Circulation.2004; 110: 2535-2537.
37. Douglas PS, Ryan TJ, Beller GA, Hines EF Jr, Livingston DW, McEntee CW, Brown NA, Collishaw KJ, Garson A Jr, Robertson RM, Smith SC Jr, Whitman GR. ACC/AHA Bethesda Conference on Ethics and Professionalism. Task force 6: Code of conduct for staff and volunteer leadership. J Am Coll Cardiol. 2004 Oct 19;44(8):1750-3.
38.
Eyre H, Kahn
R, Robertson RM, and the ACS/ADA/AHA Collaborative Writing Committee
,
Clark NG, Doyle C, Gansler T, Glynn T, Hong Y, Smith RA, Taubert K, Thun MJ. Preventing
Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American
Cancer Society, the American Diabetes Association, and the American Heart
Association. CA Cancer J Clin 2004;
54:190-207.
39. Robertson RM, Taubert KA. Warning signs for heart attack and stroke: what more can we do? J Cardiopulm Rehabil. 2005;25: 40-2.
40. Eckel RH, Daniels SR, Jacobs AK, Robertson RM. America's children: a critical time for prevention. Circulation. 2005 Apr 19;111(15):1866-8.
41. Veazie MA, Galloway JM, Matson-Koffman D, LaBarthe DR, Brownstein JN, Emr M, Bolton E, Freund E Jr, Fulwood R, Guyton-Krishnan J, Hong Y, Lebowitz M, Ochiai E, Schoeberl M, Robertson RM; American Heart Association. Taking the initiative: implementing the American Heart Association Guide for Improving Cardiovascular Health at the Community Level: Healthy People 2010 Heart Disease and Stroke Partnership Community Guideline Implementation and Best Practices Workgroup. Circulation. 2005 Oct 18;112(16):2538-54.
C. Abstracts
.
1. Stevens RM, Baird MG, Fuhrmann CG, Rouleau J, Summer WR, Strauss HW, Pitt B: Detection of right ventricular hypertrophy by Thallium 201 myocardial perfusion imaging. Circ 1975; 51 & 52: suppl II: 234.
2. Robertson RM, Robertson D, and Friesinger GC: An echocardiographic‑physiologic index of the severity of mitral stenosis. Am J Cardiol 1978; 41: 383.
3. Rigo P, Alderson PO, Robertson RM, Becker LC: Measurement of valvular regurgitation by gated cardiac blood pool scans. Circ 1979; 58: suppl II: 5.
4. Robertson D, Robertson RM, Friesinger GC, Oates JA: Sympathetic nervous system function in variant angina pectoris. Am J Cardiol 1979; 43: 344.
5. Wood AJJ, Robertson RM, Wilkinson GR, Wood M: Effect of cardiac catheterization on the free levels of diazepam and propranolol. Circ 1979; 60: suppl II: 264.
6. Robertson RM, Robertson D, Nies AP, Friesinger GC, Oates JA, Oelz O: The effect of indomethacin on variant angina pectoris. Clin Res 1979; 27: 199A.
7. Robertson RM, Perry JM, Smith CW, Robertson D: Coronary and hemodynamic responses to intravenous ergonovine in man. Clin Res 1979; 27: 733A.
8. Robertson D, Maas RL, Roberts LJ, Friesinger GC, Oates JA, Robertson RM. Antiplatelet agents in vasospastic angina: A double‑blind cross‑over study. Clin Res 1980; 28: 242A.
9. Kronenberg MW, Robertson RM, Steckley RA, Born ML, Robertson D, Friesinger GC, Rollo FD. Reactive hyperemia in man ‑ probable demonstration by thallium scintigraphy during variant angina. Clin Res 1980; 28: 188A.
10. Robertson RM, Bernard Y, Smith CW, Perry JM, Robertson D: Ergonovine ‑ induced discrepancy between direct and indirect arterial pressure recording. Clin Res 1980; 28: 242A.
11. Robertson RM, Maas RL, Roberts LJ, Boeynaems JM, Albert KA, Friesinger GC, Oates JA, Robertson D: Role of thromboxane in variant angina pectoris. Clin Res 1980; 28: 206A.
12. Graham TP, Robertson RM, Boucek RJ, Boerth RC, Breitweser JA, Parrish MD, Thompson S: Assessment of ventricular size and function in congenitally corrected transposition of the great arteries (CCTGA) Circ 1980; 62; suppl III: 115.
13. Robertson D, Bernard Y, Robertson RM: Cardiogenic reflexes associated with spontaneous coronary artery spasm in patients with vasotonic angina pectoris. Circ 1980; 62; suppl III: 312.
14. Robertson RM, Bernard Y, Maas RL, Roberts LJ II, Friesinger GC, Oates JA, Robertson D: Variant angina: The role of thromboxane A2. Circ 1980; 62: suppl III: 310.
15. Steckley RA, Robertson RM, Kronenberg MW, Born ML, Robertson D, Friesinger GC, Rollo FD: Excess regional thallium uptake: Possible demonstration of reactive hyperemia in man. Soc Nuclear Med, June, 1980.
16. Robertson D, Wood AJJ, Bernard Y, Robertson RM: Propranolol in vasotonic angina pectoris. Clin Res 1980; 28: 813A.
17. Smith R, Gundersen S, Wikswo J, Robertson D, Robertson RM: Determinants of QRS change in variant angina. Clin Res 1980; 28: 881A.
18. Robertson RM, Bernard Y, Robertson D: The placebo response in vasotonic angina: A critical factor in drug trial design. Am J Cardiol 1981; 47: 398.
19. Robertson RM, Wood AJJ, Bernard Y, Robertson D: Exacerbation of ischemia in vasotonic angina pectoris by propranolol. Am J Cardiol 1981; 47: 463.
20. Robertson D, Goldberg MR, Bernard Y, Robertson RM: Coronary artery spasm: The role of the sympathetic nervous system. Clin Res 1981; 29: 234A.
21. Robertson RM, Robertson D, Bernard YD: Coronary sinus and arterial catecholamines during coronary artery spasm. Circ 1981; 64: 933.
22. Carey EL, Robertson D, Wells JN, Robertson RM: Contraction of isolated porcine coronary arteries is inhibited by propranolol. Clin Res 1981; 29: 809A.
23. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM: Clonidine raises blood pressure in idiopathic orthostatic hypotension. Circ 1981; 64: suppl IV: 10.
24. Friesinger GC, Robertson RM, Robertson D, FitzGerald GA, Roberts LJ, Maas R, Oates JA: Variant angina: The role of thromboxane A2. Proceedings of the IVth Symposium on Ischemic Heart Disease. Springer, 1982.
25. Robertson RM, Robertson D, Davison R, Kaplan K, Haywood LJ, Goldstein S, Lee T, Mehta J, Conti CR, Simpson RJ: Verapamil in rest angina: A randomized, placebo‑controlled multi‑center study. Clin Res 1982; 30: 85A.
26. Carey EL, Robertson D, Wells JN, Robertson RM: Contraction of isolated porcine coronary arteries is inhibited by propranolol. Am J Cardiol 1982; 49: 941.
27. Bernard YD, Robertson RM, Robertson D: Vasotonic angina without EKG changes: A technical critique. Am J Cardiol 1982; 49: 954.
28. Roy L, Knapp HR, Robertson RM, FitzGerald GA: Endogenous prostacyclin (PGI2) biosynthesis is stimulated by cardiac catheterization (CC) and angiography (A) in man. Circulation 1983; 68: 413.
29. Fitzgerald DJ, Roy L, Robertson RM, FitzGerald GA: The effects of short and long acting nitrates on in vivo prostacyclin (PGI2) release and platelet function in man. Clin Res 1983; 31:821A.
30. Fitzgerald DJ, Roy L, Robertson RM, FitzGerald GA. Failure of short and long acting nitrates to alter in vitro prostacyclin biosynthesis in man. Clin Res 1984;32:164A.
31. Robertson RM, Northington J, Hoover P, Robertson D: Evidence for post‑junctional alpha‑2 adrenoreceptors in porcine coronary vein. Clin Res 1984;32:200A.
32. Forman MB, Roy L, Uderman H, Bostick D, Bernard Y, Robertson D, Robertson RM: The effect of indomethacin on coronary and systemic hemodynamics in man: Evidence for a direct action. Clin Res 1984;32:165A.
33. Cates C, Virmani R, Vaughn WK, Robertson RM: Cardiac metastases: A specific electrocardiographic marker. J Am Coll Card 1985;5:512.
34. Robertson RM, Liston T, Tantengco MV, Roberts LJ, II: Human coronary arteries are contracted by a novel prostaglandin. Clin Res 1985;77:221A.
35. Robertson RM, Tantengco, MV, Bernard Y, Gore T, Robertson D: Effect of caffeine on serum lipids in miniature swine. Clin Res 1985;33:221A.
36. Biaggioni I, Olafsson B, Robertson RM, Robertson D. Adenosine stimulates carotid body chemoreceptors in man. Circulation 1986; 74: 214.
37. Robertson RM, Tantengco MV, Prince CR, Gore TB, Atkinson JB, Virmani R, Wells JN: Vascular responsiveness in porcine coronary arteries is altered by an atherogenic diet. J Am Coll Card 1986;7:58A.
38. Kroft PA, Atkinson JB, Overholser KA, Robertson RM: Effect of in vitro shear stress on porcine atherosclerotic plaques. Fed Proc 1986;45:172.
39. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D: Adenosine infusion stimulates respiration in man. Clin Res 1986; 34:395A.
40. Olafsson B, Biaggioni I, Robertson RM, Hollister AS, Robertson D: The hemodynamic and respiratory effects of adenosine boluses are not antagonized by aminophylline in man. Clin Res 1986; 34:405A.
41. Roberts LJ II, Siebert K, Liston TE, Tantengco MV, Robertson RM:PGD2 is transformed by human coronary arteries to 9að ,11bð ‑PGF2 which contracts human coronary artery rings. Sixth International Conference on Prostaglandins and Related Compounds. Florence, 1986.
42. Robertson RM, Tantengco MVT, Light RT, Robertson D: Neuropeptide Y is a vasoconstrictor of human coronary arteries. Circ 1986; (Suppl)74:II-86.
43. Tantengco MVT, Robertson RM: An indirect adrenergic action of histamine in porcine coronary arteries. Circ 1986; (Suppl) 74:II-87.
44. Piper PJ, Galton SA, Robertson RM: Leukotriene (LT) metabolism in the pulmonary (PULM) circulation. Circ 1986; (Suppl) 74:II-240.
45. Piper PJ, Galton SA, Robertson RM: Leukotriene (LT)C4: bioenhancement in the coronary (cor) circulation (circ). Circ 1986; (Suppl) 74:II-88
46. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D: Characteristics of adenosine-induced stimulation respiration in man. Pflugers Arch Eur J Physiol 1986; 407:S55.
47. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D: Failure of aminophylline to antagonize the hemodynamic and respiratory effects of adenosine. Pflugers Arch Eur J Physiol 1986; 407:S54.
48. Prince CR, Tantengco MV, Virmani R, Light RT, Friesinger GC, Robertson RM: In vivo and in vitro coronary vascular reactivity in hyperlipidemic swine. J Am Coll Cardiol 1987; (Suppl A) 9:210A.
49. Biaggioni I, Hollister AS, Robertson RM, Robertson D: Dopamine-beta-hydroxylase deficiency in man. Circ 1987; (Suppl) 76:IV-299.
50. Robertson D, Biaggioni I, Hollister AS, Robertson RM. Successful treatment of dopamine-beta-hydroxylase deficiency with precursor therapy. Sixth International Symposium on Catecholamines 1987; 7.
51. Rea RF, Biaggioni I, Robertson RM, Haile V, Robertson D. Reflex control of muscle sympathetic nerve activity in dopamine-beta-hydroxylase deficiency. Clin Res 1988; 36:826A.
52. Haugh CJ, Atkinson JB, Bluth RF, Swift LL, Robertson RM: Genetically-induced atherosclerosis augments vascular smooth muscle contraction. Arteriosclerosis 1988; 8:623A.
53. Haugh CJ, Atkinson JB, Bluth RF, Swift LL, Robertson RM: Genetically-induced atherosclerosis attenuates endothelially mediated relaxation. J Am Coll Card 1989; 13:32A.
54. Atkinson JB, Virmani R, Tantengco MV, Merrill WH, Frist WH, Robertson RM: Influence of age and atherosclerosis on coronary reactivity. Lab Invest 1989; 60:3A.
55. Mosqueda-Garcia R, Tseng C-J, Biaggioni I, Haile V, Robertson RM, Robertson D: Caffeine attenuates baroreflex activity in man. Clin Res 1989; 37:340A.
56. Hill JO, Jones HA, Yerby MA, Robertson RM: Effects of weight loss on blood pressure in obese hypertensive humans. Presented at the 1989 Annual Meeting of the American Dietetic Association.
57. Jones HA, Yerby MA, Reed G, Robertson RM, Hill JO: Weight loss in obese hypertensive humans: Effects on blood pressure and energy expenditure. Int'l J Obesity 1989.
58. Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D: Adenosine increases sympathetic nerve traffic in man. Circulation 1989; (Suppl II)80:II-90.
59. Chilukuri MB, Susawa T, Yerby AB, Zhang LQ, Zimmer JA, Robertson RM, Collins JC: Computer-aided assessment of vascular reactivity in subjects with essential hypertension. Proceedings of the 11th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. November 9-12, 1989; 1989-1990.
60. Robertson RM, Susawa T, Jones HA, Hill JO, Reed GW: Weight loss affects vascular reactivity in obese hypertensives. J Am Coll Card 1990; 15(2):101A.
61. Mosqueda-Garcia R, Biaggioni I, Haile V, Robertson RM, Robertson D: Effects of nicotine infusion on sympathetic nerve traffic and baroreflex responses in man. Soc Neurosci Clinical Research 1990; 38(2):259A.
62. Robertson RM, Susawa T, Sugiura M, Haile V, Inagami T. Circulating endothelin levels: modulation by heart failure in man. Clinical Research 1990; 38(2):414A.
63. Mosqueda-Garcia R, Beck C, Robertson RM, Appalsamy M, Robertson D. Contrasting cardiovascular effects of microinjection of endothelin-1, and -3 in the brainstem of normotensive rats. Neuroscience, 1990; 16:12.
64. Robertson RM, Susawa T, Jones H, Killian TJ, Warner J, Reed G, Zimmer J, Richards PJ, Hill J. Vascular reactivity in obese hypertensives is altered by weight loss. Circulation 1990; 82:III-63
65. Killian TJ, Robertson D, Biaggioni I, Haile V, Biscaia I, Robertson RM. Sympathetic nervous system function in man is enhanced by acetylcholinesterase inhibition. Circulation 1990; 82:III-636.
66. Killian TJ, Robertson D, Biaggioni I, Haile V, Biscaia I, Robertson RM. Enhanced pressor effect of yohimbine with MAO inhibition in idiopathic orthostatic hypotension. Circulation 1990; 82:III-637.
67. Mosqueda-Garcia R, Killian TJ, Hash J, Tseng CJ, Robertson RM, Robertson D: Effects of caffeine on plasma catecholamines and muscle sympathetic nerve activity in man. Circulation 1990;82:III-335.
68. Mosqueda-Garcia R, Sugiura M, Beck C, Inagami T, Robertson RM. Cerebrospinal fluid levels and central cardiovascular effects of microinjection of endothelin in the brainstem of anesthetized rats. Circulation 1990; 82:III-453.
69. O'Leary JA, Appalsamy M, Robertson RM, Robertson D, Mosqueda-Garcia R. Autonomic effects of microinjection of endothelin-1 in the caudal ventrolateral medulla of anesthetized rats. Clin Pharm Ther 1991;49:141.
70. Appalsamy M, O'Leary JA, Robertson RM, Mosqueda-Garcia R. The central cardiorespiratory depression of endothelin-1 is mediated by neuronal action in the ventrolateral medulla. Clin Res 1991; 39:172A.
71. Mosqueda-Garcia R, Inagami T, Hamakubo T, Robertson RM. Central pressor action of endothelin in spontaneously hypertensive rats. Abstracts of the Council for High Blood Pressure Research 1991; 45: 48.
72. Mosqueda-Garcia R, Inagami T, Robertson RM. Endothelin as a neuropeptide: central cardiovascular effects. IBRO Abstracts 1991;III:126.
73. Krishnamani MRS, Phillips JA, Summar ML, Biaggioni I, Haile VF, Robertson RM. Genetic analysis of the atrial natriuretic factor gene in familial orthostatic intolerance. International Congress of Human Genetics, 1991.
74. Robertson RM, Killian TJ, Biaggioni I, Haile V, Mosqueda-Garcia R. Sympathetic nervous sytem activity is increased by acetylcholinesterase inhibition in humans. JACC 1992;19:130A.
75. Robertson RM, Killian TJ, Biaggioni I, Mosqueda-Garcia R, Haile V, Davis R, Robertson D. Manipulation of norepinephrine metabolism in the treatment of autonomic failure. Clin Res 1992;40:366A.
76. Robertson D, Hollister AS, Biaggioni I, Mosqueda-Garcia R, Robertson RM. Baroreceptor failure in man. Hypertension 1992;20:406.
77. Biaggioni I, Haile V, Robertson RM. The hypertension of autonomic failure. Hypertension 1992;20:422
78. Mosqueda-Garcia R, Inagami T, Appalsamy M, Robertson RM. Microinjection of an endothelin antagonist into the nucleus tractus solitarii facilitates baroreflex activation. Soc Neuroscience 1992;18:1189.
79. Stainback RF, Robertson RM, Mosqueda-Garcia R. Cardiovascular effects of microinjection of endothelin-1 in circumventricular organs of the rat. Circulation 1992;86: I-141.
80. Robertson D, Hollister AS, Biaggioni I, Netterville JL, Mosqueda-Garcia R,Robertson RM. Arterial baroreflex failure in man. Clin Autonom Res 1993: 3:212.
81. Robertson RM, Killian TJ, Baiggioni I, Mosqueda-Garcia R, Haile V, Davis R, Robertson D. Manipulation of noradrenaline metabolism in the treatment of autonomic failure. Clin Autonom Res 1993: 3:219.
82. Robertson RM, Killian TJ, Biaggioni I, Haile V, Mosqueda-Garcia R. Sympathetic nervous sytem activity is increased by acetylcholinesterase inhibition in humans. JACC 992;19:130A.
83. Stainback RF, Biaggioni I, Robertson D, Robertson RM. Electrophysiological effects of intravenous acetylcholine in orthotopic cardiac transplantation patients. JACC 1994;20 :227A
84. Robertson RM, Fritz JD, Hale N, Davis TL, Robertson D. Gene-based modulation of neurotransmitter production: Studies of human GAD65 and GAD67. Clin Autonom Res 1995: 5:33q.
85. Mosqueda-Garcia R, Inagami T, Robertson RM. Endothelin as a neuropeptide: central cardiovascular effects. IBRO Abstracts 1991; III:126
86. Jacob G, Ertl A, Shannon J, Costa F, Robertson RM, Robertson D. Proposed mechanism for the primary hyperadrenergic state in orthostatic intolerance.Clinical Autonomic Research 1996; 6:297
87. Ertl A, Jacob G, Shannon J, Robertson RM, Robertson D. Evaluation of concomitant neurohumoral and plasma volume responses to the upright posture in normals Clinical Autonomic Research 1996; 6:296
88. Jacob G, Wathen M, Robertson RM, Costa F, Shannon J, Biaggioni I, Mosqueda-Garcia R, Furlan R, Robertson D. The function of systemic and local cardiovascular adrenoreceptors in orthostatic intolerance: evidence of partial dysautonomia Clinical Autonomic Research 1996 ; 6:296
89. Shannon J, Jacob G, Mosqueda-Garcia R, Black B, Robertson RM, Biaggioni I, Robertson D. Effects of volume loading and pressor agents in orthostatic intolerance. Clinical Autonomic Research 1996; 6:286
90. Jacob G, Costa F, Robertson RM, Biaggioni I, Black B, Roberton D. Evidence of Beta2-Adrenoreceptor Downregulation in Forearm of Patients with Primary Hyperadrenergic State. Circulation 1996 94(Suppl. 1): I-341
91. Shannon J, Robertson RM, Biaggioni I. Treatment of Hypertension in Autonomic Failure. Circulation 1996;94 (Suppl. 1): I-458
92. Jacob G, Ertl A, Shannon J, Robertson RM, Robertson D, Idiopathic Orthostatic Tachycardia: The Role of Dynamic Orthostatic Hypovolemia and Norepinephrine. Circulation 1996 94 (Suppl. 1) I-627
93. Jacob G, Mosqueda-Garcia R, Ertl AC, Biaggioni I, Robertson RM, Robertson D. Hyporeninemia: a novel form of orthostatic intolerance. J Invest Med 1996; 44:337.
94. Jacob G, Ertl AC, Robertson RM, Robertson D. Dynamic orthostatic hypotension. J Invest Med 1996; 44:273.
95. Jordan J, Shannon J, Grogan E, Biaggioni I, Black B, Robertson RM, Robertson D. Pressor Effects of Oral Water in Primary Autonomic Failure. Circ 1997; 96: 4156
96. Jacob G, Robertson RM, Costa F, Wathen M, Stein M, Black B, Biaggioni I, Robertson D. The Local Norepinephrine Spillover in Arms and Legs of Patients with Idiopathic Orthostatic Intolerance: Evidence of Partial Dysautonomia.Clin Aut Res 1997; 7:235.
97. Robertson RM, Mosqueda-Garcia R, Norman R, Paranjape SY, Robertson D. Central muscarinic M-1 receptor stimulation: hemodynamic and neurohumoral effects. Clin Aut Res 1997; 7:260.
98. Jordan J, Shannon JR, Biaggioni I, Robertson RM, Norman R, Black B, Robertson D. Contrasting actions of pressor agents in severe autonomic failure. Clin Aut Res 1997; 7:261.
99. Joos KM, Donahue S, Robertson RM, Mosqueda Garcia R, Biaggioni I, Robertson D Intraocular pressure change as a function of positional blood pressure in patients with multiple system atrophy (MSA). Invest Ophthal and Vis Sci 1997; 38: 4944
100. Jordan J, Shannon JR, Grogan E, Farley MG, Biaggioni I, Robertson RM, Robertson D. The acute pressor effect of drinking water. J Hypertension 1998;16: 14W2 , Suppl. 2
101. Shannon JR, Jordan J, Diedrich A, Biaggioni I, Robertson RM, Robertson D..Water drinking: An effective treatment for orthostatic and post-prandial hypotension in autonomic failure. Circulation 102: (18) 700-700 Suppl. 2000
102. Ernst FA, Shah N, Diedrich A, Paranjape S, Wells D, Garland E, Robertson RM. Effective regulation of anger and blood pressure are related. Circulation 102: (18) 701-701 Suppl. 2000
103. Tellioglu T, Black B, Watkins V, Farley G, Robertson D, Robertson RM, Robertson D, Biaggioni I. Contribution of renal mechanisms to the hypertension of autonomic failure. Circulation 2001; 104: 3497
104. Mosca L, Robertson RM, Hill M. Trends in awareness and knowledge of heart disease risk and prevention in US women: Results of an AHA nationally representative follow-up survey. Circulation 2001; 104: 3713
105.
Diedrich A, Jordan J, Shannon J, Tank J, Luft FC, Robertson
RM, Robertson D, Biaggioni I. Human
models of sympathetically-mediated hypertension. Hypertension 2001; 38: 62
D. Book Chapters
1. Robertson RM: Digitalis. Chapter in Robertson D and Smith CR. eds. Manual of Clinical Pharmacology (Baltimore: Williams and Wilkins), 1981.
2. Robertson D, Robertson RM: The role of the platelet in vasotonic angina. Chapter 8 in Mehta J. and Mehta P., eds., Platelets and Prostaglandins in Cardiovascular Disease (New York: Futura) 1981, pp. 359‑368.
3. Robertson RM, Robertson D, FitzGerald GA, Oates JA: The role of prostaglandins in ischemic cardiac syndromes. Chapter 12 in Condorelli M, Marone G and Lichtenstein L.M., eds., Advances in Clinical Immunology: The role of chemical mediators in pulmonary and cardiac diseases, (Florence: O.I.C. Medical Press) 1981, pp. 173-190.
4. Robertson D, Robertson RM: Calcium antagonists. Chapter 18 in Wood M. and Wood A., eds., Drugs and Anesthesia: Pharmacology for Anesthesiologists (Maryland: Williams & Wilkins) 1982, pp. 565‑574.
5. Friesinger GC, Robertson RM: Reversible coronary artery obstruction: Clinical implications. Advances in Internal Medicine, Year Book Medical Publishers, Vol. 28, 1983.
6. Robertson RM, Wood AJJ, Vaughn WK, Robertson D: Beta-blockade in vasotonic angina pectoris. In: Theroux P, Waters DD, eds., Nifedipine in Clinical Practice: Proceedings of the First International Canadian Nifedipine Symposium, (New Jersey: Excerpta Medica) 1983, pp.18-26.
7. Robertson D, Hollister AS, Robertson RM: The autonomic nervous system in vasotonic angina. In: Theroux P, Waters DD, eds., Nifedipine in Clinical Practice: Proceedings of the First International Canadian Nifedipine Symposium. (New Jersey: Excerpta Medica) 1983,ä pp. 41‑47.
8. Robertson D, Friesinger GC, Kronenberg MW, Hollister AS, Robertson RM: ST‑segment alterations in normal subjects and in patients with vasotonic angina. Chapter 20 in: V Hombach and HH Hilger, eds., Holter Monitoring Techniques (Berlin: Schattauer) 1984, pp. 203‑210.
9. Robertson RM: Variant Angina. In: Fortuin NJ, ed., Current Therapy in Cardiovascular Disease 1984‑1985, (Philadelphia: B.C. Deckner, Inc.) 1984, pp. 37‑43.
10. Robertson RM, Kronenberg MW, Friesinger GC, Robertson D: Silent myocardial ischemia in vasotonic angina. In Rutishauer W and Roskamm H eds., Silent Myocardial Ischemia (Berlin: Springer‑Verlag) 1984, 111‑116.
11. Robertson RM, Robertson D, Friesinger GC: Vasotonic Angina. Chapter 5 in Julian DG, ed., Angina Pectoris (New York: Churchill Livingstone, Inc.), 2nd Edition, 1985, pp. 38‑52.
12. Friesinger GC, Robertson RM: Hemodynamics in Stable Angina Pectoris. Chapter 4 in Julian DG, ed., Angina Pectoris (New York: Churchill Livingstone, Inc.), 1985, pp. 25‑37.
13. Robertson RM, Robertson D: Platelets and anti‑platelet drugs in unstable angina. Chapter 13 in Plotnick GD, ed., Unstable Angina (New York: Futura Publishing Co., Inc.) 1985, pp. 295‑314.
14. Forman M, Robertson RM: Current treatment of coronary spasm: advantages and disadvantages of beta blockers. In Conti RC, ed., Coronary Artery Spasm (Marcell Dekkar, Inc.) 18:273-295, 1986.
15. Biaggioni I, Jackson EK, Robertson RM, Robertson D. Caffeine and hypertension. In: Enwonwu, CO, ed., Nutrition and Hypertension in Blacks and Other Minorities. Annual Nutrition Workshop Series (Nashville: Vaughn, Inc.) 2:199-206, 1989.
16. Mosqueda-Garcia R, Robertson D, Robertson RM. The cardiovascular effects of caffeine. In Garattini S, ed., Caffeine, Coffee and Health (New York: Raven Press.) 1993, pp 157-176.
17. Robertson RM, Convertino V: Autonomic Responses to Microgravity and Bedrest: Dysfunction or Adaptation? In Robertson D, Biaggioni I, eds., Disorders of the Autonomic Nervous System (Harwood Academic, Reading, U.K.) 1995, pp. 311-333.
18. Robertson RM, Robertson D: Drugs used for the treatment of angina. Chapter 32 in Hardman JG, Limbird LE eds., Goodman and Gilman's Ninth Edition: The Pharmacological Basis of Therapeutics (McGraw-Hill; New York). 1996, pp. 759-779.
19. Robertson RM. Baroreflex failure. In Robertson D, Law PA, Polinsky RJ, eds, Primer of the Autonomic Nervous System (Academic Press; San Diego). 1996, pp. 197-201.
20. Robertson RM, Kerins D, Robertson D: Drugs used for the treatment of angina. Chapter 32 in Hardman JG, Limbird LE eds., Goodman and Gilman's Tenth Edition: The Pharmacological Basis of Therapeutics (McGraw-Hill; New York). 2001
21. Robertson RM, Robertson D: Cardiovascular Manifestations of Autonomic Disorders. In Zipes DP, Libby P, Bonow RO, Braunwald E, eds, Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine (Elsevier Saunders; Philadephia) 2005, 2173-2183.
10/24/05